| Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer | Nature communications |  | | 2026 | 64 | 42 |
|
| Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab | Gynecologic Oncology Reports | | | 2021 | 268 | 154 |
|
| Automated Detection of Arm-Level Alterations for Individual Cancer Patients in the Clinical Setting | The journal of molecular diagnostics | | | 2021 | 207 | 359 |
|
| Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss | Cancer Biology and Therapy | | | 2020 | 359 | 221 |
|
